Treatment for Urticaria
Second-generation H1-antihistamines are the first-line treatment for urticaria, with doses that can be increased up to four times the standard dose for refractory cases. 1
Initial Management
First-Line Treatment
- Start with a second-generation H1-antihistamine at standard dosing:
- Fexofenadine 180mg daily
- Cetirizine 10mg daily
- Loratadine 10mg daily 1
Step-Up Approach
If inadequate response after 1-2 weeks:
- Step 1: Standard dose second-generation H1-antihistamine
- Step 2: Increase dose up to 4× standard dose if inadequate response
- Step 3: Add leukotriene receptor antagonist (e.g., montelukast) or consider advanced therapies 1
Treatment Based on Urticaria Type
Chronic Spontaneous Urticaria
- For patients ≥12 years with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment, omalizumab is FDA-approved 2
- Dosing of omalizumab for CSU is not dependent on serum IgE levels or body weight 2
- Validated tools like Urticaria Control Test (UCT) and Urticaria Activity Score (UAS7) should be used to monitor disease control 1
Acute Urticaria
- Most cases are self-limited and resolve within days to weeks with appropriate treatment 1
- Limited evidence suggests that adding systemic corticosteroids to antihistamines does not significantly improve symptoms 3
Physical Urticarias
- For symptomatic dermographism, combination therapy with H1 antihistamines and H2 antagonists (e.g., cimetidine, ranitidine) has shown better efficacy than H1 antihistamines alone 1, 4
Advanced Treatment Options for Refractory Cases
Third-Line Options
For patients with inadequate response to high-dose antihistamines:
- Omalizumab: Particularly effective for chronic spontaneous urticaria 1, 2
- Cyclosporine: For resistant cases 1
- Other alternatives: Tacrolimus, mycophenolate mofetil, dapsone, sulfasalazine, and tranexamic acid 1
Topical Treatments
- Topical doxepin may provide relief but should be limited to 8 days and 10% of body surface area (maximum 12g daily) due to risk of allergic contact dermatitis 1
Special Considerations
Anaphylaxis Management
- If urticaria is accompanied by signs of anaphylaxis (respiratory distress, vomiting, lethargy):
- Administer epinephrine 0.3 mg IM in the mid-antrolateral thigh as first-line treatment
- Follow with combined H1+H2 blockade (diphenhydramine 1-2 mg/kg or 25-50 mg IV plus ranitidine 50 mg IV)
- Seek immediate emergency medical attention 1
First-Generation Antihistamines
- Use cautiously due to sedative effects
- May be useful for nighttime symptoms when pruritus interferes with sleep 1
- Examples include diphenhydramine and hydroxyzine
Monitoring and Follow-Up
- Reassess within 1-2 weeks of initiating or changing therapy 1
- Follow the principle of "as much as needed and as little as possible" for medication use 1
- Extensive laboratory workup is unnecessary for most cases of urticaria unless specific underlying conditions are suspected 1
Common Pitfalls to Avoid
Inadequate dosing: Many patients require higher than standard antihistamine doses. Studies show approximately 75% of patients with difficult-to-treat chronic urticaria respond to higher than conventional antihistamine doses 5
Premature discontinuation: More than half of patients with chronic urticaria will have resolution or improvement of symptoms within a year, so continued treatment may be necessary 6
Missing anaphylaxis: Failure to identify anaphylaxis can be critical. Always assess for systemic symptoms 1
Overuse of corticosteroids: Limited evidence supports their routine use in acute urticaria 3